Review



goat polyclonal anti smad4 antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems goat polyclonal anti smad4 antibody
    (A) PLA utilizes a pair of oligonucleotide-conjugated secondary antibodies that bind corresponding antibodies targeting each interacting protein partner. The proximity of these two protein partners allows circular DNA amplification of the oligonucleotides template upon in situ ligation. Fluorescent probes complementary to this amplicon engender a detectable signal via fluorescence microscopy. Plasma membrane permeabilization was used for intracellular protein interactions. (B and C) PLA indicating protein-protein interactions of PAI-1 and low-density LRP1 on the cell surface (B) or intracellular (C) due to ASC-CM exposure in the presence or absence of the LRP1 inhibitor RAP. Representative micrograph images showing positive signal (red) for PAI-1/LRP1 interactions. DAPI was used to stain nuclei (blue). (D) ChIP-qPCR analysis of LRP1-ICD binding to two promoter regions of the <t>SMAD4</t> gene in control (Ctrl) cells and CM-exposed cells treated and untreated with RAP (5 μg/mL). Data represent mean ± SD, n = 3 technical replicates; **p < 0.01, ***p < 0.001. (E) qRT-PCR analysis of mRNA expression levels of SMAD4 gene in control cells and CM-exposed cells treated and untreated with Tip (50 μM) or RAP (5 μg/mL). Data represent mean ± SD, n = 3 technical replicates; *p < 0.05. (F) PLA demonstrating protein-protein interactions of SMAD4 and ubiquitin due to ASC-CM exposure in the presence or absence of the following inhibitors: Tip for PAI-1, RAP for LRP1, and protease inhibitor MG132. Micrograph images showing positive PLA signal (green) for SMAD4-ubiquitin interactions. DAPI was used to stain nuclei (blue). (G) Protein expression of LRP1 and SMAD4 by capillary western immunoassays. Endometrial epithelial EME6/7t cells were treated with control media, ASC-CM, and ASC-CM plus Tip, or with pre-treatment with LRP1 antagonist RAP or protease inhibitor MG132. The result shown is a representative of three independent experiments. See also .
    Goat Polyclonal Anti Smad4 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Human+Smad4+Antibody/pmc07641039-308-24-29
    Average 93 stars, based on 18 article reviews
    goat polyclonal anti smad4 antibody - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer"

    Article Title: PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer

    Journal: Cell reports

    doi: 10.1016/j.celrep.2020.108253

    (A) PLA utilizes a pair of oligonucleotide-conjugated secondary antibodies that bind corresponding antibodies targeting each interacting protein partner. The proximity of these two protein partners allows circular DNA amplification of the oligonucleotides template upon in situ ligation. Fluorescent probes complementary to this amplicon engender a detectable signal via fluorescence microscopy. Plasma membrane permeabilization was used for intracellular protein interactions. (B and C) PLA indicating protein-protein interactions of PAI-1 and low-density LRP1 on the cell surface (B) or intracellular (C) due to ASC-CM exposure in the presence or absence of the LRP1 inhibitor RAP. Representative micrograph images showing positive signal (red) for PAI-1/LRP1 interactions. DAPI was used to stain nuclei (blue). (D) ChIP-qPCR analysis of LRP1-ICD binding to two promoter regions of the SMAD4 gene in control (Ctrl) cells and CM-exposed cells treated and untreated with RAP (5 μg/mL). Data represent mean ± SD, n = 3 technical replicates; **p < 0.01, ***p < 0.001. (E) qRT-PCR analysis of mRNA expression levels of SMAD4 gene in control cells and CM-exposed cells treated and untreated with Tip (50 μM) or RAP (5 μg/mL). Data represent mean ± SD, n = 3 technical replicates; *p < 0.05. (F) PLA demonstrating protein-protein interactions of SMAD4 and ubiquitin due to ASC-CM exposure in the presence or absence of the following inhibitors: Tip for PAI-1, RAP for LRP1, and protease inhibitor MG132. Micrograph images showing positive PLA signal (green) for SMAD4-ubiquitin interactions. DAPI was used to stain nuclei (blue). (G) Protein expression of LRP1 and SMAD4 by capillary western immunoassays. Endometrial epithelial EME6/7t cells were treated with control media, ASC-CM, and ASC-CM plus Tip, or with pre-treatment with LRP1 antagonist RAP or protease inhibitor MG132. The result shown is a representative of three independent experiments. See also .
    Figure Legend Snippet: (A) PLA utilizes a pair of oligonucleotide-conjugated secondary antibodies that bind corresponding antibodies targeting each interacting protein partner. The proximity of these two protein partners allows circular DNA amplification of the oligonucleotides template upon in situ ligation. Fluorescent probes complementary to this amplicon engender a detectable signal via fluorescence microscopy. Plasma membrane permeabilization was used for intracellular protein interactions. (B and C) PLA indicating protein-protein interactions of PAI-1 and low-density LRP1 on the cell surface (B) or intracellular (C) due to ASC-CM exposure in the presence or absence of the LRP1 inhibitor RAP. Representative micrograph images showing positive signal (red) for PAI-1/LRP1 interactions. DAPI was used to stain nuclei (blue). (D) ChIP-qPCR analysis of LRP1-ICD binding to two promoter regions of the SMAD4 gene in control (Ctrl) cells and CM-exposed cells treated and untreated with RAP (5 μg/mL). Data represent mean ± SD, n = 3 technical replicates; **p < 0.01, ***p < 0.001. (E) qRT-PCR analysis of mRNA expression levels of SMAD4 gene in control cells and CM-exposed cells treated and untreated with Tip (50 μM) or RAP (5 μg/mL). Data represent mean ± SD, n = 3 technical replicates; *p < 0.05. (F) PLA demonstrating protein-protein interactions of SMAD4 and ubiquitin due to ASC-CM exposure in the presence or absence of the following inhibitors: Tip for PAI-1, RAP for LRP1, and protease inhibitor MG132. Micrograph images showing positive PLA signal (green) for SMAD4-ubiquitin interactions. DAPI was used to stain nuclei (blue). (G) Protein expression of LRP1 and SMAD4 by capillary western immunoassays. Endometrial epithelial EME6/7t cells were treated with control media, ASC-CM, and ASC-CM plus Tip, or with pre-treatment with LRP1 antagonist RAP or protease inhibitor MG132. The result shown is a representative of three independent experiments. See also .

    Techniques Used: DNA Amplification, In Situ, Ligation, Amplification, Fluorescence, Microscopy, Clinical Proteomics, Membrane, Protein-Protein interactions, Staining, ChIP-qPCR, Binding Assay, Control, Quantitative RT-PCR, Expressing, Ubiquitin Proteomics, Protease Inhibitor, Western Blot

    (A) Bar plots showing mRNA expression levels of selected PAI1-regulated JAC genes by qRT-PCR in the two sh SMAD4 knockdown clones, compared to shCtrl in the presence or absence of ASC-CM. (B) ChIP-qPCR analysis of SMAD4 binding to promoter regions of the JAC genes in control (Ctrl) cells and ASC-CM-exposed cells. Data represent mean ± SD, n = 3 technical replicates; *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test. See also .
    Figure Legend Snippet: (A) Bar plots showing mRNA expression levels of selected PAI1-regulated JAC genes by qRT-PCR in the two sh SMAD4 knockdown clones, compared to shCtrl in the presence or absence of ASC-CM. (B) ChIP-qPCR analysis of SMAD4 binding to promoter regions of the JAC genes in control (Ctrl) cells and ASC-CM-exposed cells. Data represent mean ± SD, n = 3 technical replicates; *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test. See also .

    Techniques Used: Expressing, Quantitative RT-PCR, Knockdown, Clone Assay, ChIP-qPCR, Binding Assay, Control

    (A and B) tSNE plots of mass cytometry (CyTOF) analysis visualizing 74,048 epithelial cells, which were divided into clusters (n = 27) based on their proteomic profiles (A). These cells included immortalized EEC line EME6/7t (exposed to ASC-CM ± Tip) and primary endometrial tumors of patients with known BMIs (B). (C) tSNE-based phenographs showing abundance and cellular distributions of JAC proteins. (D) tSNE-based phenographs showing EpCAM and CK8/18 as epithelial cell markers and TGFR-2, SMAD2, and SMAD4 as TGF-β factors. See also and and .
    Figure Legend Snippet: (A and B) tSNE plots of mass cytometry (CyTOF) analysis visualizing 74,048 epithelial cells, which were divided into clusters (n = 27) based on their proteomic profiles (A). These cells included immortalized EEC line EME6/7t (exposed to ASC-CM ± Tip) and primary endometrial tumors of patients with known BMIs (B). (C) tSNE-based phenographs showing abundance and cellular distributions of JAC proteins. (D) tSNE-based phenographs showing EpCAM and CK8/18 as epithelial cell markers and TGFR-2, SMAD2, and SMAD4 as TGF-β factors. See also and and .

    Techniques Used: Mass Cytometry

    (A–C) Expression profiles of SMAD4 and JAC based on CyTOF were classified into five categories: I, II, III, IV, and V. Violin plots show ordered SMAD4 expression level (low to high) and distribution in the individual subpopulations (A). Expression heatmaps of JAC were aligned according to SMAD4 expression levels (in descending order) in different cellular subpopulations (B). Area of circle denotes relative cell proportion of a subpopulation within each sample and ordered in the aforementioned five categories in cellular subpopulations of EME6/7t lines and primary tumors (C). Tumors were ordered from top to bottom based on increased patients’ BMIs and histology classes. (D) Balloon plots of subpopulation distributions of endometrial tumors in the five categories based on histology and BMI. Circle area indicates the size of each subpopulation. Categories IV and V were associated with relatively high expression levels of SMAD4 and JAC, whereas low levels of SMAD4 and JAC were noted in categories I, II, and III. (E) Violin plots showing the average expression levels of four JAC markers—ADAM15, ROCK1, Cx43, and Gas1—based on patients’ tumor histology: papillary serous and endometrioid. (F) Balloon plots of subpopulation distributions in the five categories stratified by BMI into three groups: normal weight (NW), obesity (OB), and morbid obesity (MOB). (G) Violin plots showing the average expression levels of ADAM15, ROCK1, Cx43, and Gas1, based on three BMI groups: NW, OB, and MOB. Lower JAC expressions corresponded with patients with higher BMIs. ****p < 0.0001. See also .
    Figure Legend Snippet: (A–C) Expression profiles of SMAD4 and JAC based on CyTOF were classified into five categories: I, II, III, IV, and V. Violin plots show ordered SMAD4 expression level (low to high) and distribution in the individual subpopulations (A). Expression heatmaps of JAC were aligned according to SMAD4 expression levels (in descending order) in different cellular subpopulations (B). Area of circle denotes relative cell proportion of a subpopulation within each sample and ordered in the aforementioned five categories in cellular subpopulations of EME6/7t lines and primary tumors (C). Tumors were ordered from top to bottom based on increased patients’ BMIs and histology classes. (D) Balloon plots of subpopulation distributions of endometrial tumors in the five categories based on histology and BMI. Circle area indicates the size of each subpopulation. Categories IV and V were associated with relatively high expression levels of SMAD4 and JAC, whereas low levels of SMAD4 and JAC were noted in categories I, II, and III. (E) Violin plots showing the average expression levels of four JAC markers—ADAM15, ROCK1, Cx43, and Gas1—based on patients’ tumor histology: papillary serous and endometrioid. (F) Balloon plots of subpopulation distributions in the five categories stratified by BMI into three groups: normal weight (NW), obesity (OB), and morbid obesity (MOB). (G) Violin plots showing the average expression levels of ADAM15, ROCK1, Cx43, and Gas1, based on three BMI groups: NW, OB, and MOB. Lower JAC expressions corresponded with patients with higher BMIs. ****p < 0.0001. See also .

    Techniques Used: Expressing

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Ubiquitin Proteomics, Recombinant, Multiplex Assay, Reverse Transcription, SYBR Green Assay, In Situ, shRNA, Software

    Related Articles

    Staining:

    Article Title: SMAD4 Expression in Monocytes as a Potential Biomarker for Atherosclerosis Risk in Patients with Obstructive Sleep Apnea.
    Article Snippet: .. Then, cells were stained with anti-human CD14 (BV510) (BD Biosciences, Aalst, Belgium), anti-human SMAD4 (AF488) (R&D Systems, Minneapolis, MN, USA), and anti-human NLRP3 (phycoerythrin) (Miltenyi Biotec, Bergisch Gladbach, Germany), following a standard protocol for intracellular staining (Transcription Factor Buffer Set, BD Biosciences, Aalst, Belgium). ..

    other:

    Article Title: PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer
    Article Snippet: Cells were incubated with rabbit polyclonal anti-LRP-1 antibody (1:250, Cell Signaling Technology, Cat# 64099S) and mouse monoclonal anti-PAI-1 antibody (1:200, Santa Cruz Biotechnology, Cat# sc-5297), which were tagged with anti-rabbit PLUS and anti-mouse MINUS probes.

    Control:

    Article Title: PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer
    Article Snippet: Anti-rabbit or anti-mouse detection module and anti-goat secondary antibodies were used for Wes per the manufacturer’s recommendation (ProteinSimple). .. Primary antibodies used were as follows: LRP1 (1:25, Cell Signaling Technology, Cat# 64099S), SMAD4 (1:10, R&D Systems, Cat# AF2097), and b-actin (1:200, R&D Systems, Cat# MAB8929) as a housekeeping control. ..



    Similar Products

    93
    fluidigm multiplex pcr
    Multiplex Pcr, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Access+Array/pmc11610102-57-0-10
    Average 93 stars, based on 1 article reviews
    multiplex pcr - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    fluidigm chapter 6 multiplex pcr
    Chapter 6 Multiplex Pcr, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Access+Array/us12018323-1615-16-27
    Average 93 stars, based on 1 article reviews
    chapter 6 multiplex pcr - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    fluidigm multiplex polymerase chain reaction pcr amplification
    Multiplex Polymerase Chain Reaction Pcr Amplification, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Access+Array/pm37481994-25-15-26
    Average 93 stars, based on 1 article reviews
    multiplex polymerase chain reaction pcr amplification - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    fluidigm multiplex polymerase chain reaction pcr
    Multiplex Polymerase Chain Reaction Pcr, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Access+Array/pm32088313-49-12-25
    Average 93 stars, based on 1 article reviews
    multiplex polymerase chain reaction pcr - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    fluidigm access array system multiplex pcr amplification
    Access Array System Multiplex Pcr Amplification, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Access+Array/10__3310_slash_eme08010-486-5-4
    Average 93 stars, based on 1 article reviews
    access array system multiplex pcr amplification - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    fluidigm access array multiplex pcr
    Access Array Multiplex Pcr, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/Access+Array/pmc07064999-39-22-21
    Average 93 stars, based on 1 article reviews
    access array multiplex pcr - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    fluidigm barcoded multiplex pcr 48.48 access arrays system
    Barcoded Multiplex Pcr 48.48 Access Arrays System, supplied by fluidigm, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/access+array+multiplex+pcr/barcoded+multiplex+pcr+48+48+access+arrays+system/pmc06399484-282-4-10
    Average 90 stars, based on 1 article reviews
    barcoded multiplex pcr 48.48 access arrays system - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results